Login -
Region: North America
         

VELA Diagnostics

Skip navigation
  • Home
  • Solutions
    • Next-Generation Sequencing
    • Near-Patient Testing
    • Real-Time PCR
    • Sentosa FLEX
    • Pharma Partnering
  • Products
    • Laboratory Testing
      • NGS
      • PCR
      • Labware
      • Consumables
    • Near-Patient Testing
    • Symbol Glossary
  • Instruments & Systems
    • NGS Instruments
      • SX101
      • SQ301
      • ST401
    • PCR Instruments and Systems
      • SA201
      • SX101
      • RGQ
      • GB Analyzer
  • Support
    • Technical Support
    • Order Management
  • Company
    • At a Glance
    • Corporate Values
    • Management Team
    • Careers
    • Contact
      • Contact Form
      • Global Distributors
  • Newsroom
    • Press Releases
    • Events
    • Multimedia
      • Reference Lab Seminar
      • KOL Seminar
      • Webinars
    • Publications
  • Blog
 
Skip navigation
  • Home
  • Solutions
    • Next-Generation Sequencing
    • Near-Patient Testing
    • Real-Time PCR
    • Sentosa FLEX
    • Pharma Partnering
  • Products
    • Laboratory Testing
      • NGS
      • PCR
      • Labware
      • Consumables
    • Near-Patient Testing
    • Symbol Glossary
  • Instruments & Systems
    • NGS Instruments
      • SX101
      • SQ301
      • ST401
    • PCR Instruments and Systems
      • SA201
      • SX101
      • RGQ
      • GB Analyzer
  • Support
    • Technical Support
    • Order Management
  • Company
    • At a Glance
    • Corporate Values
    • Management Team
    • Careers
    • Contact
      • Contact Form
      • Global Distributors
  • Newsroom
    • Press Releases
    • Events
    • Multimedia
      • Reference Lab Seminar
      • KOL Seminar
      • Webinars
    • Publications
  • Blog
 
Skip navigation
  • PCR
    • Tests
      • Zoonotic Diseases
        • MPXV
      • Microbiology
        • Direct MRSA/SA
        • UTI ID & AMR
      • Human Herpes and Polyomaviruses
        • BKV Quant
        • CMV Quant
        • EBV Quant
        • HSV-1/2 Quant
        • HSV-1/2 Qual
        • VZV Quant
        • ISP FLEX
        • HHV6 Quant
      • Leukemia
        • BCR-ABL(M)Qt
        • BCR-ABL(m)Qt
      • Respiratory Viruses
        • Influenza A/B & RSV
        • SARS-CoV-2 v2.0
        • SARS-CoV-2 ID
        • Flu/RSV/SARS-CoV-2
    • Instruments
      • RGQ
      • SA201
      • SX101
    • Software
      • SA Reporter
      • SA201 Reporter
    • Extraction Kits
      • Total RNA
      • Virus Total NA
      • Virus Total NA Plus
      • Whole Blood
  • NGS
    • Tests
      • Oncology
        • NSCLC
        • OncoKey Core
        • OncoKey Focus
        • Leukemia
        • OncoKey Hereditary
      • Virology
        • HCV GT v2.0
        • HIV-1
        • HIV/HCV/HBV/CMV FLEX
        • SARS-CoV-2 FLEX
      • Microbiology
        • Pathogen ID
    • Library Preparation
      • Fragm Library Prep
    • Template Preparation / Sequencing
      • 318 Chip
      • Sequencing Kit
      • Template Kit
    • Instruments
      • SX101
      • SQ301
      • ST401
    • Software
      • SQ Reporter
  • Labware
  • Consumables
  • Symbol Glossary
 
  • Global Provider of Integrated PCR & NGS Solutions ...
  • »
  • Newsroom
  • »
  • Press Releases - Archive

Press Releases - Archive

Please select a year:

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012

2015

December 11, 2015

Luye Builds China Cancer Diagnosis Capability Via Vela Investment

Read more >

November 30, 2015

Vela Diagnostics’s Sentosa® SQ HCV Genotyping Assays shown 100% clinical accuracy and sensitivity

Read more >

November 25, 2015

Vela Diagnostics Rolled Out Sentosa® Next Generation Sequencing Workflow at Institute Gustave Roussy for Routine Diagnosis

Read more >

September 21, 2015

Vela Diagnostics Receives TGA Approval for Four Next-Generation Sequencing Oncology Panels

Read more >

September 21, 2015

Vela Diagnostics Announces Launch of CE-IVD and TGA approved Thyroid Cancer Next-Generation Sequencing Panel

Read more >

September 14, 2015

Vela Diagnostics Officially Out Of Judicial Management

Read more >

July 24, 2015

Vela Diagnostics and Luye Group Ltd Sign New Investment and Collaboration Agreement

Read more >

February 10, 2015

Vela Diagnostics Announces Launch of CE-IVD Non-Small Cell Lung Cancer Next-Generation Sequencing Panel

Read more >

January 20, 2015

Vela Diagnostics Launches HCV Genotyping Next-Generation Sequencing Assay

Read more >

January 13, 2015

Vela Diagnostics Launches CE-IVD Colorectal Cancer Next-Generation Sequencing Panel

Read more >

Skip navigation
  • Newsroom
 
Skip navigation
  • Press Releases
  • Events
  • Multimedia
    • Reference Lab Seminar
    • KOL Seminar
    • Webinars
  • Publications
 

qPCR Solutions
Next-Gen Sequencing Solutions
qPCR Tests
Next-Gen Sequencing Assays

Sentosa SX101
Rotor-Gene® Q MDx
Sentosa SQ301 Sequencer
Labware
Consumables

Press Releases
Events
Multimedia

At a Glance
Corporate Values
Management Team
Careers

Company
Support
Contact

Terms of Use  |  Personal Data Protection Statement  |  Sitemap |  Cookie Policy

 
 
 
 
 

© 2022 Vela Diagnostics

 
Disclaimer: All products listed here are by Vela Diagnostics. The products listed on this site are to be used by trained personnel only. All products are to be used only in accordance with local laws, regulations and package instructions. Not all products may be available in all countries. Please contact your local Vela Diagnostics representative for questions about product availability in your country. OncoKey®, PathoKey®, VELA® and ViroKey® are registered trademarks of Vela Diagnostics Holding Pte Ltd in several markets including the US, EU, PRC and the UK. Sentosa® is a registered trademark of Vela Diagnostics Holding Pte Ltd outside Singapore in several markets including the US, EU, PRC and the UK. All Sentosa® products mentioned above are by Vela Diagnostics. All other product names, trademarks and logos are the property of their respective owners.